Φορτώνει......

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study

BACKGROUND: Anthracycline-based adjuvant chemotherapy improves survival in patients with high-risk node-negative breast cancer (BC). In this setting, prognostic factors predicting for treatment failure might help selecting among the different available cytotoxic combinations. METHODS: Between 1998 a...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:	BMC Cancer
Κύριοι συγγραφείς:	Rahal, S., Boher, J M, Extra, J M, Tarpin, C., Charafe-Jauffret, E., Lambaudie, E., Sabatier, R., Thomassin-Piana, J., Tallet, A., Resbeut, M., Houvenaeghel, G., Laborde, L., Bertucci, F., Viens, P., Gonçalves, A.
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BioMed Central 2015
Θέματα:	Research Article
Διαθέσιμο Online:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4607139/ https://ncbi.nlm.nih.gov/pubmed/26466893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1746-3
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study

Παρόμοια τεκμήρια